Structure

Physi-Chem Properties

Molecular Weight:  448.26
Volume:  484.063
LogP:  5.114
LogD:  3.303
LogS:  -4.282
# Rotatable Bonds:  2
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.374
Synthetic Accessibility Score:  5.076
Fsp3:  0.552
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.863
MDCK Permeability:  2.2172087483340874e-05
Pgp-inhibitor:  0.053
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.953
30% Bioavailability (F30%):  0.06

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.071
Plasma Protein Binding (PPB):  96.052001953125%
Volume Distribution (VD):  1.386
Pgp-substrate:  5.770342826843262%

ADMET: Metabolism

CYP1A2-inhibitor:  0.104
CYP1A2-substrate:  0.925
CYP2C19-inhibitor:  0.095
CYP2C19-substrate:  0.784
CYP2C9-inhibitor:  0.185
CYP2C9-substrate:  0.221
CYP2D6-inhibitor:  0.428
CYP2D6-substrate:  0.12
CYP3A4-inhibitor:  0.645
CYP3A4-substrate:  0.909

ADMET: Excretion

Clearance (CL):  8.886
Half-life (T1/2):  0.486

ADMET: Toxicity

hERG Blockers:  0.107
Human Hepatotoxicity (H-HT):  0.66
Drug-inuced Liver Injury (DILI):  0.045
AMES Toxicity:  0.199
Rat Oral Acute Toxicity:  0.366
Maximum Recommended Daily Dose:  0.839
Skin Sensitization:  0.053
Carcinogencity:  0.908
Eye Corrosion:  0.003
Eye Irritation:  0.1
Respiratory Toxicity:  0.939

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC263780

Natural Product ID:  NPC263780
Common Name*:   17-(Methoxycarbonyl)-28-Nor-Isoiguesterin
IUPAC Name:   methyl (4aS,6aR,6aS,14aS,14bS)-10-hydroxy-6a,6a,9,14a-tetramethyl-2-methylidene-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-4a-carboxylate
Synonyms:  
Standard InCHIKey:  CPFUJAKVJBYWJA-BTRWLOMLSA-N
Standard InCHI:  InChI=1S/C29H36O4/c1-17-9-10-29(25(32)33-6)14-13-27(4)22-8-7-19-18(2)24(31)21(30)16-20(19)26(22,3)11-12-28(27,5)23(29)15-17/h7-8,16,23,31H,1,9-15H2,2-6H3/t23-,26-,27+,28-,29-/m0/s1
SMILES:  C=C1CC[C@@]2(CC[C@]3(C)C4=CC=C5C(=C(C(=O)C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)O)C)C(=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL515027
PubChem CID:   10411393
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0001093] Carboxylic acid derivatives
          • [CHEMONTID:0001238] Carboxylic acid esters
            • [CHEMONTID:0003416] Methyl esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26085 Salacia kraussii Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[9644053]
NPO26085 Salacia kraussii Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens IC50 = 2.38 ug.mL-1 PMID[488465]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 0.0276 ug.mL-1 PMID[488465]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.0371 ug.mL-1 PMID[488465]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC263780 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9884 High Similarity NPC470036
0.9884 High Similarity NPC174167
0.9651 High Similarity NPC112454
0.9551 High Similarity NPC777
0.8989 High Similarity NPC68148
0.8989 High Similarity NPC65615
0.8966 High Similarity NPC474680
0.8953 High Similarity NPC53733
0.8913 High Similarity NPC147232
0.8901 High Similarity NPC211230
0.8851 High Similarity NPC96095
0.8804 High Similarity NPC474882
0.8763 High Similarity NPC213366
0.875 High Similarity NPC474537
0.8736 High Similarity NPC105803
0.8736 High Similarity NPC70834
0.8721 High Similarity NPC475863
0.8721 High Similarity NPC471898
0.8636 High Similarity NPC53385
0.8621 High Similarity NPC251779
0.8621 High Similarity NPC69101
0.8605 High Similarity NPC287063
0.8605 High Similarity NPC104545
0.8602 High Similarity NPC23170
0.8602 High Similarity NPC474328
0.8571 High Similarity NPC477973
0.8571 High Similarity NPC474700
0.8539 High Similarity NPC33881
0.8539 High Similarity NPC132228
0.8539 High Similarity NPC6185
0.8539 High Similarity NPC263997
0.8539 High Similarity NPC241512
0.8539 High Similarity NPC8518
0.8523 High Similarity NPC291999
0.8523 High Similarity NPC200752
0.8523 High Similarity NPC309309
0.8506 High Similarity NPC278459
0.8506 High Similarity NPC274050
0.8506 High Similarity NPC470034
0.8506 High Similarity NPC267691
0.8506 High Similarity NPC162632
0.8506 High Similarity NPC142244
0.8506 High Similarity NPC225515
0.8506 High Similarity NPC55869
0.8506 High Similarity NPC263272
0.8495 Intermediate Similarity NPC295643
0.8495 Intermediate Similarity NPC272075
0.8495 Intermediate Similarity NPC214756
0.8488 Intermediate Similarity NPC199595
0.8488 Intermediate Similarity NPC192329
0.8478 Intermediate Similarity NPC46441
0.8478 Intermediate Similarity NPC252737
0.8469 Intermediate Similarity NPC179208
0.8462 Intermediate Similarity NPC1753
0.8462 Intermediate Similarity NPC474511
0.8462 Intermediate Similarity NPC474474
0.8404 Intermediate Similarity NPC80365
0.8404 Intermediate Similarity NPC74751
0.8391 Intermediate Similarity NPC37038
0.8391 Intermediate Similarity NPC18955
0.8391 Intermediate Similarity NPC108955
0.8391 Intermediate Similarity NPC267517
0.8391 Intermediate Similarity NPC477057
0.8387 Intermediate Similarity NPC301244
0.8387 Intermediate Similarity NPC233455
0.8387 Intermediate Similarity NPC4036
0.8387 Intermediate Similarity NPC474525
0.8387 Intermediate Similarity NPC65120
0.8387 Intermediate Similarity NPC145067
0.8387 Intermediate Similarity NPC158030
0.8372 Intermediate Similarity NPC260385
0.8372 Intermediate Similarity NPC280654
0.8372 Intermediate Similarity NPC110094
0.8352 Intermediate Similarity NPC477228
0.8352 Intermediate Similarity NPC173089
0.8352 Intermediate Similarity NPC158141
0.8352 Intermediate Similarity NPC71507
0.8333 Intermediate Similarity NPC469993
0.8316 Intermediate Similarity NPC295347
0.8295 Intermediate Similarity NPC121984
0.828 Intermediate Similarity NPC198818
0.828 Intermediate Similarity NPC474728
0.8276 Intermediate Similarity NPC16394
0.8276 Intermediate Similarity NPC231431
0.8276 Intermediate Similarity NPC27817
0.8256 Intermediate Similarity NPC107039
0.8256 Intermediate Similarity NPC165711
0.8256 Intermediate Similarity NPC471899
0.8256 Intermediate Similarity NPC472300
0.8256 Intermediate Similarity NPC471897
0.8242 Intermediate Similarity NPC324063
0.8242 Intermediate Similarity NPC56588
0.8229 Intermediate Similarity NPC62516
0.8229 Intermediate Similarity NPC269492
0.8229 Intermediate Similarity NPC9487
0.8229 Intermediate Similarity NPC157113
0.8229 Intermediate Similarity NPC98874
0.8222 Intermediate Similarity NPC156981
0.8222 Intermediate Similarity NPC312660
0.8202 Intermediate Similarity NPC310989
0.8202 Intermediate Similarity NPC103486
0.8191 Intermediate Similarity NPC77099
0.8191 Intermediate Similarity NPC230064
0.8191 Intermediate Similarity NPC38754
0.8191 Intermediate Similarity NPC470590
0.8191 Intermediate Similarity NPC60755
0.8191 Intermediate Similarity NPC285184
0.8182 Intermediate Similarity NPC2482
0.8172 Intermediate Similarity NPC474686
0.8172 Intermediate Similarity NPC198664
0.8172 Intermediate Similarity NPC474972
0.8172 Intermediate Similarity NPC95246
0.8172 Intermediate Similarity NPC36668
0.8172 Intermediate Similarity NPC274330
0.8172 Intermediate Similarity NPC143232
0.8172 Intermediate Similarity NPC470588
0.8172 Intermediate Similarity NPC161751
0.8172 Intermediate Similarity NPC281524
0.8172 Intermediate Similarity NPC118011
0.8161 Intermediate Similarity NPC189485
0.8161 Intermediate Similarity NPC30321
0.8161 Intermediate Similarity NPC321514
0.8161 Intermediate Similarity NPC74410
0.8144 Intermediate Similarity NPC208094
0.8144 Intermediate Similarity NPC21728
0.8144 Intermediate Similarity NPC26413
0.8144 Intermediate Similarity NPC473456
0.814 Intermediate Similarity NPC112680
0.814 Intermediate Similarity NPC309399
0.814 Intermediate Similarity NPC92080
0.814 Intermediate Similarity NPC180886
0.814 Intermediate Similarity NPC899
0.814 Intermediate Similarity NPC89294
0.8132 Intermediate Similarity NPC133652
0.8125 Intermediate Similarity NPC139570
0.8125 Intermediate Similarity NPC139459
0.8125 Intermediate Similarity NPC148523
0.8111 Intermediate Similarity NPC470015
0.8111 Intermediate Similarity NPC102197
0.8111 Intermediate Similarity NPC69279
0.8111 Intermediate Similarity NPC83569
0.8111 Intermediate Similarity NPC168188
0.8105 Intermediate Similarity NPC133579
0.8105 Intermediate Similarity NPC169343
0.8105 Intermediate Similarity NPC474806
0.809 Intermediate Similarity NPC474085
0.809 Intermediate Similarity NPC3915
0.809 Intermediate Similarity NPC221647
0.8085 Intermediate Similarity NPC126369
0.8085 Intermediate Similarity NPC111110
0.8085 Intermediate Similarity NPC193750
0.8085 Intermediate Similarity NPC120840
0.8085 Intermediate Similarity NPC113989
0.8085 Intermediate Similarity NPC291028
0.8085 Intermediate Similarity NPC470589
0.8065 Intermediate Similarity NPC470629
0.8065 Intermediate Similarity NPC181225
0.8065 Intermediate Similarity NPC290690
0.8065 Intermediate Similarity NPC182797
0.8065 Intermediate Similarity NPC246708
0.8065 Intermediate Similarity NPC230387
0.8065 Intermediate Similarity NPC474512
0.8065 Intermediate Similarity NPC72397
0.8065 Intermediate Similarity NPC40552
0.8065 Intermediate Similarity NPC52169
0.8065 Intermediate Similarity NPC473242
0.8065 Intermediate Similarity NPC17733
0.8061 Intermediate Similarity NPC478056
0.8061 Intermediate Similarity NPC471966
0.8041 Intermediate Similarity NPC88847
0.8022 Intermediate Similarity NPC180834
0.8021 Intermediate Similarity NPC148964
0.8021 Intermediate Similarity NPC160413
0.8 Intermediate Similarity NPC260956
0.8 Intermediate Similarity NPC471588
0.8 Intermediate Similarity NPC321289
0.8 Intermediate Similarity NPC187722
0.8 Intermediate Similarity NPC327969
0.8 Intermediate Similarity NPC204341
0.8 Intermediate Similarity NPC473986
0.8 Intermediate Similarity NPC474018
0.8 Intermediate Similarity NPC320514
0.8 Intermediate Similarity NPC6255
0.8 Intermediate Similarity NPC105189
0.7979 Intermediate Similarity NPC225585
0.7979 Intermediate Similarity NPC234346
0.7979 Intermediate Similarity NPC64872
0.7979 Intermediate Similarity NPC130520
0.7979 Intermediate Similarity NPC121798
0.7979 Intermediate Similarity NPC263393
0.7979 Intermediate Similarity NPC469546
0.7979 Intermediate Similarity NPC475049
0.7979 Intermediate Similarity NPC61543
0.7979 Intermediate Similarity NPC30522
0.7979 Intermediate Similarity NPC293048
0.7979 Intermediate Similarity NPC290972
0.7979 Intermediate Similarity NPC25906
0.7979 Intermediate Similarity NPC270768
0.7979 Intermediate Similarity NPC59263
0.7979 Intermediate Similarity NPC127689

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC263780 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9651 High Similarity NPD7285 Clinical (unspecified phase)
0.8404 Intermediate Similarity NPD7748 Approved
0.8391 Intermediate Similarity NPD4695 Discontinued
0.8387 Intermediate Similarity NPD7515 Phase 2
0.8144 Intermediate Similarity NPD7902 Approved
0.8065 Intermediate Similarity NPD6672 Approved
0.8065 Intermediate Similarity NPD5737 Approved
0.8 Intermediate Similarity NPD6050 Approved
0.7959 Intermediate Similarity NPD6084 Phase 2
0.7959 Intermediate Similarity NPD6083 Phase 2
0.7938 Intermediate Similarity NPD5695 Phase 3
0.7895 Intermediate Similarity NPD5692 Phase 3
0.7872 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7614 Phase 1
0.7849 Intermediate Similarity NPD5280 Approved
0.7849 Intermediate Similarity NPD4694 Approved
0.7849 Intermediate Similarity NPD5279 Phase 3
0.7835 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7835 Intermediate Similarity NPD7900 Approved
0.7812 Intermediate Similarity NPD5694 Approved
0.7812 Intermediate Similarity NPD5281 Approved
0.7812 Intermediate Similarity NPD5284 Approved
0.7789 Intermediate Similarity NPD6904 Approved
0.7789 Intermediate Similarity NPD6080 Approved
0.7789 Intermediate Similarity NPD6673 Approved
0.7753 Intermediate Similarity NPD3617 Approved
0.7742 Intermediate Similarity NPD5329 Approved
0.7732 Intermediate Similarity NPD6399 Phase 3
0.77 Intermediate Similarity NPD5696 Approved
0.7677 Intermediate Similarity NPD7732 Phase 3
0.766 Intermediate Similarity NPD7334 Approved
0.766 Intermediate Similarity NPD6409 Approved
0.766 Intermediate Similarity NPD5330 Approved
0.766 Intermediate Similarity NPD7146 Approved
0.766 Intermediate Similarity NPD6684 Approved
0.766 Intermediate Similarity NPD7521 Approved
0.7634 Intermediate Similarity NPD4197 Approved
0.7604 Intermediate Similarity NPD4753 Phase 2
0.75 Intermediate Similarity NPD6903 Approved
0.7474 Intermediate Similarity NPD6098 Approved
0.7474 Intermediate Similarity NPD5690 Phase 2
0.7449 Intermediate Similarity NPD5693 Phase 1
0.7449 Intermediate Similarity NPD6411 Approved
0.7447 Intermediate Similarity NPD3665 Phase 1
0.7447 Intermediate Similarity NPD3666 Approved
0.7447 Intermediate Similarity NPD4786 Approved
0.7447 Intermediate Similarity NPD3133 Approved
0.7429 Intermediate Similarity NPD6675 Approved
0.7429 Intermediate Similarity NPD7128 Approved
0.7429 Intermediate Similarity NPD6402 Approved
0.7429 Intermediate Similarity NPD5739 Approved
0.7419 Intermediate Similarity NPD4223 Phase 3
0.7419 Intermediate Similarity NPD3667 Approved
0.7419 Intermediate Similarity NPD4221 Approved
0.74 Intermediate Similarity NPD5654 Approved
0.7396 Intermediate Similarity NPD3573 Approved
0.7347 Intermediate Similarity NPD5207 Approved
0.7292 Intermediate Similarity NPD3618 Phase 1
0.729 Intermediate Similarity NPD6881 Approved
0.729 Intermediate Similarity NPD7320 Approved
0.729 Intermediate Similarity NPD6899 Approved
0.7255 Intermediate Similarity NPD5959 Approved
0.7245 Intermediate Similarity NPD5328 Approved
0.7245 Intermediate Similarity NPD6101 Approved
0.7245 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD5210 Approved
0.7228 Intermediate Similarity NPD4629 Approved
0.7222 Intermediate Similarity NPD6372 Approved
0.7222 Intermediate Similarity NPD6373 Approved
0.7204 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD5133 Approved
0.7196 Intermediate Similarity NPD5697 Approved
0.7196 Intermediate Similarity NPD5701 Approved
0.7157 Intermediate Similarity NPD5221 Approved
0.7157 Intermediate Similarity NPD5222 Approved
0.7157 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD4697 Phase 3
0.7156 Intermediate Similarity NPD7290 Approved
0.7156 Intermediate Similarity NPD6883 Approved
0.7156 Intermediate Similarity NPD7102 Approved
0.7143 Intermediate Similarity NPD5208 Approved
0.713 Intermediate Similarity NPD6011 Approved
0.7113 Intermediate Similarity NPD4689 Approved
0.7113 Intermediate Similarity NPD4623 Approved
0.7113 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD4693 Phase 3
0.7113 Intermediate Similarity NPD4519 Discontinued
0.7113 Intermediate Similarity NPD4690 Approved
0.7113 Intermediate Similarity NPD4138 Approved
0.7113 Intermediate Similarity NPD5205 Approved
0.7113 Intermediate Similarity NPD4688 Approved
0.7111 Intermediate Similarity NPD5733 Approved
0.71 Intermediate Similarity NPD6079 Approved
0.7091 Intermediate Similarity NPD6650 Approved
0.7091 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD8130 Phase 1
0.7091 Intermediate Similarity NPD6847 Approved
0.7091 Intermediate Similarity NPD6869 Approved
0.7091 Intermediate Similarity NPD6649 Approved
0.7091 Intermediate Similarity NPD6617 Approved
0.7087 Intermediate Similarity NPD5173 Approved
0.7087 Intermediate Similarity NPD4755 Approved
0.7083 Intermediate Similarity NPD3668 Phase 3
0.7065 Intermediate Similarity NPD4756 Discovery
0.7064 Intermediate Similarity NPD6012 Approved
0.7064 Intermediate Similarity NPD6014 Approved
0.7064 Intermediate Similarity NPD6013 Approved
0.7053 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD8297 Approved
0.7027 Intermediate Similarity NPD6882 Approved
0.7019 Intermediate Similarity NPD7638 Approved
0.701 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4096 Approved
0.6979 Remote Similarity NPD4788 Approved
0.697 Remote Similarity NPD4518 Approved
0.6952 Remote Similarity NPD6404 Discontinued
0.6952 Remote Similarity NPD7639 Approved
0.6952 Remote Similarity NPD5285 Approved
0.6952 Remote Similarity NPD5286 Approved
0.6952 Remote Similarity NPD4700 Approved
0.6952 Remote Similarity NPD4696 Approved
0.6952 Remote Similarity NPD7640 Approved
0.6931 Remote Similarity NPD8035 Phase 2
0.6931 Remote Similarity NPD8034 Phase 2
0.6923 Remote Similarity NPD4058 Approved
0.6923 Remote Similarity NPD4687 Approved
0.6915 Remote Similarity NPD7645 Phase 2
0.6889 Remote Similarity NPD5276 Approved
0.6887 Remote Similarity NPD5223 Approved
0.6881 Remote Similarity NPD6412 Phase 2
0.6864 Remote Similarity NPD8328 Phase 3
0.6863 Remote Similarity NPD5779 Approved
0.6863 Remote Similarity NPD5778 Approved
0.6863 Remote Similarity NPD4202 Approved
0.6854 Remote Similarity NPD4137 Phase 3
0.6842 Remote Similarity NPD6868 Approved
0.6822 Remote Similarity NPD5211 Phase 2
0.6822 Remote Similarity NPD5225 Approved
0.6822 Remote Similarity NPD5224 Approved
0.6822 Remote Similarity NPD4633 Approved
0.6822 Remote Similarity NPD5226 Approved
0.6814 Remote Similarity NPD4632 Approved
0.6796 Remote Similarity NPD6001 Approved
0.6783 Remote Similarity NPD7115 Discovery
0.6778 Remote Similarity NPD4747 Approved
0.6778 Remote Similarity NPD4691 Approved
0.6771 Remote Similarity NPD8028 Phase 2
0.6759 Remote Similarity NPD4754 Approved
0.6759 Remote Similarity NPD5174 Approved
0.6759 Remote Similarity NPD5175 Approved
0.6737 Remote Similarity NPD4195 Approved
0.6727 Remote Similarity NPD6614 Approved
0.6724 Remote Similarity NPD6335 Approved
0.6697 Remote Similarity NPD5141 Approved
0.6696 Remote Similarity NPD6274 Approved
0.6667 Remote Similarity NPD7100 Approved
0.6667 Remote Similarity NPD7094 Approved
0.6667 Remote Similarity NPD7101 Approved
0.6667 Remote Similarity NPD6858 Approved
0.6667 Remote Similarity NPD5091 Approved
0.6638 Remote Similarity NPD6317 Approved
0.6638 Remote Similarity NPD6009 Approved
0.6636 Remote Similarity NPD6008 Approved
0.6636 Remote Similarity NPD4768 Approved
0.6636 Remote Similarity NPD4767 Approved
0.6607 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6606 Remote Similarity NPD6052 Approved
0.6598 Remote Similarity NPD4139 Approved
0.6598 Remote Similarity NPD4692 Approved
0.6581 Remote Similarity NPD6314 Approved
0.6581 Remote Similarity NPD6313 Approved
0.6555 Remote Similarity NPD6909 Approved
0.6555 Remote Similarity NPD6908 Approved
0.6552 Remote Similarity NPD2664 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6081 Approved
0.6518 Remote Similarity NPD6686 Approved
0.6518 Remote Similarity NPD5168 Approved
0.6518 Remote Similarity NPD4729 Approved
0.6518 Remote Similarity NPD4730 Approved
0.6518 Remote Similarity NPD5128 Approved
0.6517 Remote Similarity NPD7331 Phase 2
0.6517 Remote Similarity NPD4224 Phase 2
0.6504 Remote Similarity NPD7736 Approved
0.65 Remote Similarity NPD1696 Phase 3
0.65 Remote Similarity NPD1694 Approved
0.6496 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6489 Remote Similarity NPD6942 Approved
0.6489 Remote Similarity NPD7339 Approved
0.6489 Remote Similarity NPD8039 Approved
0.648 Remote Similarity NPD7260 Phase 2
0.6476 Remote Similarity NPD5282 Discontinued
0.6471 Remote Similarity NPD6319 Approved
0.6446 Remote Similarity NPD7604 Phase 2
0.6442 Remote Similarity NPD7637 Suspended
0.6421 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6417 Remote Similarity NPD5983 Phase 2
0.6417 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6413 Remote Similarity NPD4789 Approved
0.6404 Remote Similarity NPD4634 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data